WO2012010685A2 - Antitranspirants contenant de l'alcool et du sel double - Google Patents

Antitranspirants contenant de l'alcool et du sel double Download PDF

Info

Publication number
WO2012010685A2
WO2012010685A2 PCT/EP2011/062611 EP2011062611W WO2012010685A2 WO 2012010685 A2 WO2012010685 A2 WO 2012010685A2 EP 2011062611 W EP2011062611 W EP 2011062611W WO 2012010685 A2 WO2012010685 A2 WO 2012010685A2
Authority
WO
WIPO (PCT)
Prior art keywords
weight
kai
aluminum
composition according
preferred
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2011/062611
Other languages
German (de)
English (en)
Other versions
WO2012010685A3 (fr
Inventor
Bernhard Banowski
Barbara Heide
Claudia Weiler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of WO2012010685A2 publication Critical patent/WO2012010685A2/fr
Anticipated expiration legal-status Critical
Publication of WO2012010685A3 publication Critical patent/WO2012010685A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols

Definitions

  • Antiperspirant or antiperspirant compositions are an important part of daily personal hygiene. They should ensure that the sweat production is reduced and formed sweat does not lead to unpleasant body odor.
  • Antiperspirant active ingredients in particular based on aluminum salts, are already well known in the art. The use of alum, KAI (S0 4) 2 ⁇ 12 H 2 0, as deodorant for reducing body odor is known. However, the known active ingredients are still in need of improvement in their sweat-reducing or deodorising effect.
  • a first object of the present invention are alcohol-containing cosmetic compositions containing a. at least one antiperspirant active ingredient selected from aluminum chlorohydroxides, aluminum zirconium chlorohydrates and mixtures thereof,
  • composition is formulated as a gel, solution or impregnated on a substrate.
  • the antiperspirant active ingredient a) is selected from aluminum chlorhydroxides, aluminum zirconium chlorohydrates and mixtures thereof.
  • Preferred antiperspirant active substances a) are water-soluble.
  • water solubility is understood as meaning a solubility of at least 5% by weight at 20 ° C., that is to say amounts of at least 5 g of the antiperspirant active are soluble in 95 g of water at 20 ° C.
  • Particularly preferred antiperspirant Wrkstoffe are selected from aluminum chlorohydrate, aluminum chlorohydrate, in particular having the general formula [Al 2 (OH) 5 CI ⁇ 1 -6 H 2 0] n, preferably [Al 2 (OH) 5 CI 2-3 ⁇ H 2 0 ] n , which may be in non-activated or in activated (depolymerized) form, and aluminum chlorohydrate having the general formula [Al 2 (OH) 4 Cl 2 ⁇ 1 -6 H 2 O] n , preferably [Al 2 (OH) 4 CI 2 ⁇ 2-3 H 2 O] n , which may be in unactivated or in activated (depolymerized) form.
  • the preparation of preferred antiperspirant agents is disclosed, for example, in US 3887692, US 3904741, US 4359456, GB 2048229 and GB 1347950.
  • aluminum sesquichlorohydrate aluminum dichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or aluminum chlorohydrex-polyethylene glycol (PEG), aluminum or aluminum zirconium glycol complexes, e.g.
  • Antiperspirant active ingredients which are particularly preferred according to the invention are selected from what are known as “activated” aluminum chlorhydroxides and aluminum zirconium chlorohydrates, which are also referred to as “antiperspirant active substances” having increased activity (English: enhanced activity). Such agents are known in the art and are also commercially available. Their preparation is disclosed, for example, in GB 2048229, US 4775528 and US 6010688. activated Fourth aluminum chlorhydroxides and aluminum zirconium chlorohydrates are typically produced by heat treating a relatively dilute solution of the salt (eg, about 10% by weight salt) to increase its HPLC peak 4-to-peak 3 area ratio. The activated salt can then be dried to a powder, in particular spray-dried. In addition to the spray drying z. B. also suitable for drum drying.
  • activated aluminum chlorhydroxides and aluminum zirconium chlorohydrates
  • Activated aluminum chlorhydroxides and aluminum zirconium chlorohydrates typically have a HPLC peak 4-to-peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9, with at least 70% of the aluminum attributable to these peaks.
  • Activated aluminum chlorhydroxides and Aluminiumzirconiumchlorhydrate can be used as spray-dried powders and - preferably - as aqueous solutions, but also as non-aqueous solutions or non-aqueous solubilizates, for example according to US 6010688, by the addition of an effective amount of a polyhydric alcohol, the 3 bis 6 carbon atoms and 3 to 6 hydroxyl groups, preferably propylene glycol, sorbitol and pentaerythritol, are stabilized against the loss of activation against the rapid degradation of the HPLC peak 4: peak 3 area ratio of the salt.
  • compositions containing by weight USP: 12-45% by weight, based on the total composition, of an activated aluminum or aluminum zirconium salt, 55-82% by weight of at least one anhydrous polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups, preferably propylene glycol, butylene glycol, diethylene glycol, dipropylene glycol, glycerol, sorbitol and pentaerythritol, more preferably propylene glycol.
  • Propylene glycol, propylene glycol / sorbitol mixtures and propylene glycol / pentaerythritol mixtures are preferred such alcohols.
  • Such inventively preferred complexes of an activated antiperspirant aluminum or aluminum zirconium salt with a polyhydric alcohol are, for. As disclosed in US 5643558 and US 6245325.
  • antiperspirant actives are basic calcium aluminum salts, as disclosed for example in US 2571030. These salts are prepared by reacting calcium carbonate with aluminum chlorhydroxide or aluminum chloride and aluminum powder or by adding calcium chloride dihydrate to aluminum chlorhydroxide.
  • antiperspirant actives are aluminum-zirconium complexes, such as those disclosed in US Pat. No. 4,017,599, which are buffered with salts of amino acids, especially alkali metal and alkaline earth glycinates.
  • antiperspirant active substances are activated aluminum or aluminum-zirconium salts, as disclosed, for example, in US Pat. No. 6,245,325 or US Pat. No. 6,042,816, containing FIG 78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in such an amount as to form an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1; 1: 20 and preferably 1: 1 to 1:10, and a water-soluble calcium salt in such an amount to have a Ca: (Al + Zr) weight ratio of 1: 1 to 1:28 and preferably 1: 2 to 1: 25 to provide.
  • Particularly preferred solid activated antiperspirant salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight. %, preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, is and so much amino acid that the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • USP 48-78% by weight
  • % preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight.
  • % preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66
  • Preferred water-soluble calcium salts for the stabilization of antiperspirant salts are selected from calcium chloride, calcium bromide, calcium nitrate, calcium citrate, calcium formate, calcium acetate, calcium gluconate, calcium ascorbate, calcium lactate, calcium glycinate, calcium carbonate, calcium sulfate, calcium hydroxide, and mixtures thereof.
  • Preferred amino acids for the stabilization of the antiperspirant salts are selected from glycine, alanine, leucine, isoleucine, beta-alanine, valine, cysteine, serine, tryptophan, phenylalanine, methionine, beta-amino-n-butanoic acid and gamma-amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • Preferred hydroxyalkanoic acids for the stabilization of the antiperspirant salts are selected from glycolic acid and lactic acid.
  • activated aluminum or aluminum zirconium salts such as disclosed in US 6902723, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, a Amino acid or hydroxyalkanoic acid in an amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10, and a water-soluble strontium salt in one such amount to provide a Sr: (AI + Zr) weight ratio of 1: 1 - 1:28 and preferably 1: 2 - 1:25.
  • Particularly preferred solid antiperspirant activated salt compositions contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 - 13 wt .-% molecularly bound water, further enough so much water-soluble strontium salt that the Sr: (AI + Zr) weight ratio 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt that the Sr: (Al + Zr) weight ratio is 1: 1 to 1:28, preferably 1: 2 to 1:25, and as much glycine, the glycine to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt that the Sr: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, and as much hydroxyalkanoic acid, the hydroxyalkanoic acid is in the (Al + Zr) weight ratio 2: 1-1: 20, preferably 1: 1-1: 10.
  • activated aluminum salts are those of the general formula Al 2 (OH) 6 . a Xa, wherein X is Cl, Br, I or N0 3 and "a" is a value of 0.3 to 5, preferably from 0.8 to 2.5 and particularly preferably 1 to 2, so that the molar ratio of Al X is 0.9: 1 to 2.1: 1, as disclosed, for example, in US 6074632.
  • These salts generally associate some hydration water, typically 1 to 6 moles of water per mole of salt.
  • Particularly preferred is aluminum chlorohydrate (ie, X is Cl in the aforementioned formula) and especially 5/6 basic aluminum chlorohydrate wherein "a” is 1 such that the molar ratio of aluminum to chlorine is 1.9: 1 to 2.1: 1 ,
  • Preferred activated aluminum-zirconium salts are those which are mixtures or complexes of the aluminum salts described above with zirconium salts of the formula ZrO (OH) 2 - pb Y b represent wherein Y is Cl, Br, I, N0 3 or S0 4, b is a rational number from 0.8 to 2 and p is the valence of Y, as disclosed, for example, in US 6074632.
  • the zirconium salts also typically associate some hydration water associatively, typically 1 to 7 moles of water per mole of salt.
  • the zirconium salt is zirconyl hydroxychloride having the formula ZrO (OH) 2 -b Cl b , wherein b is a rational number of from 0.8 to 2, preferably from 1.0 to 1.9.
  • Preferred aluminum zirconium salts have an Al: Zr mole ratio of 2 to 10 and a metal: (X + Y) ratio of 0.73 to 2.1, preferably 0.9 to 1.5.
  • a particularly preferred salt is aluminum zirconium chlorohydrate (ie, X and Y are Cl) which has an Al: Zr ratio of 2 to 10 and a molar metal: Cl ratio of 0.9 to 2.1.
  • the term aluminum-zirconium chlorohydrate includes the tri-, tetra-, penta- and octachlorohydrate forms. Other preferred antiperspirant actives are disclosed in US 6663854 and US 20040009133.
  • the antiperspirant active ingredients can be present both in solubilized and in dissolved form.
  • the antiperspirant active ingredients can be used as nonaqueous solutions or as glycolic solubilisates.
  • Preferred aluminum salts and aluminum zirconium salts have a molar metal-to-chloride ratio of 0.9-1.3, preferably 0.9-1.1, more preferably 0.9-1.0.
  • Preferred aluminum zirconium chlorohydrates generally have the empirical formula Al n Zr (OH) [3n + 4 .
  • some of the water of hydration is associatively bound to these salts, typically 1-6 moles of water per mole of salt, corresponding to 1-16% by weight, preferably 4-13% by weight of water of hydration.
  • the preferred aluminum zirconium chlorohydrates are associated with an amino acid to prevent polymerization of the zirconium species during manufacture.
  • Preferred stabilizing amino acids are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, cysteine, valine, serine, tryptophan, phenylalanine, methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • the amino acid is contained in the salt in an amount of 1 to 3 moles, preferably 1 to 3 to 1.8 moles, per mole of zirconium.
  • Aluminiumzirconiumchlorohydrat-glycine salts with Betaine are still preferred in the invention ((CH 3) 3 N + -CH 2 -COO ") are stabilized.
  • Particularly preferred corresponding compounds have a molar overall (Betaine + glycine) / Zr ratio of (0.1-3.0): 1, preferably (0.7-1.5): 1, and a betaine to glycine molar ratio of at least 0.001: 1.
  • Corresponding compounds are disclosed, for example, in US 7105691.
  • the particularly effective antiperspirant salt comprises a so-called "activated" salt, in particular one with a high HPLC peak 5-aluminum content, in particular with a peak 5 surface of at least 33%, particularly preferred at least 45%, based on the total area under the peaks 2-5, measured by HPLC of a 10% by weight aqueous solution of the active ingredient under conditions in which the aluminum species are resolved into at least 4 consecutive peaks (denoted peaks 2 - 5).
  • Preferred aluminum zirconium salts having a high HPLC peak 5-aluminum content are disclosed, for example, in US 6436381 and US 6649152.
  • Such activated "E 5 AZCH” salts are preferred, their HPLC peak 4-to-peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9.
  • Further particularly preferred antiperspirant active ingredients are those aluminum zirconium salts having a high HPLC peak 5 aluminum content, which are additionally stabilized with a water-soluble strontium salt and / or with a water-soluble calcium salt. Corresponding salts are disclosed, for example, in US Pat. No. 6,923,952.
  • compositions according to the invention contain at least one antiperspirant active ingredient in a total amount of 5 to 40% by weight, preferably 10 to 38% by weight and more preferably 13 to 35% by weight, based in each case on the total weight the anhydrous active substance (USP) in the overall composition.
  • at least one antiperspirant active ingredient in a total amount of 5 to 40% by weight, preferably 10 to 38% by weight and more preferably 13 to 35% by weight, based in each case on the total weight the anhydrous active substance (USP) in the overall composition.
  • USP anhydrous active substance
  • At least one alum-type double salt is the general one formula M I M I "(S0 4) 2 x H 2 0 ⁇ contain, where M 1 is a monovalent cation selected from potassium, sodium, rubidium, cesium and ammonium ions, M 1" is a trivalent cation, selected from aluminum, gallium, indium, scandium, titanium and vanadium ions, and x represent a rational number in the range of 0 to 12, inclusive 0.
  • KSc (S0 4 ) 2 KSc (S0 4 ) 2 , KSc (S0 4 ) 2 ⁇ 1 H 2 0, KSc (S0 4 ) 2 ⁇ 2 H 2 0, KSc (S0 4 ) 2 ⁇ 3 H 2 0, KSc (S0 4 ) 2 ⁇ 4 H 2 0, KSc (S0 4 ) 2 ⁇ 5 H 2 0, KSc (S0 4 ) 2 ⁇ 6 H 2 0, KSc (S0 4 ) 2 ⁇ 7 H 2 0, KSc (S0 4 ) 2 ⁇ 8 H 2 0, KSc (S0 4 ) 2 ⁇ 9 H 2 0, KSc (S0 4 ) 2 ⁇ 10 H 2 0, KSc (S0 4 ) 2 ⁇ 11 H z O and KSc (S0 4 ) 2 ⁇ 12 H 2 0 , NH 4 Sc (SO 4 ) 2 ,
  • KAI (S0 4 ) 2 KAI (S0 4 ) 2 , KAI (S0 4 ) 2 ⁇ 1 H 2 0, KAI (S0 4 ) 2 ⁇ 2 H 2 0, KAI (S0 4 ) 2 ⁇ 3 H 2 0, KAI (S0 4 ) 2 ⁇ 4 H 2 0, KAI (S0 4 ) 2 ⁇ 5 H 2 0, KAI (S0 4 ) 2 ⁇ 6 H 2 0, KAI (S0 4 ) 2 ⁇ 7 H 2 0, KAI (S0 4 ) 2 ⁇ 8 H 2 0, KAI (S0 4 ) 2 ⁇ 9 H 2 0, KAI (S0 4 ) 2 ⁇ 10 H 2 0, KAI (S0 4 ) 2 ⁇ 11 H z O and KAI (S0 4 ) 2 ⁇ 12 H 2 0.
  • Salts with a water content of less than 12 molecules per molecule of alum are produced by heating alum. From a temperature of about 60 ° C up to 25% of the water of crystallization already escape, preferred temperatures for further dewatering are 500 ° C or less, preferably 300 ° C or less, more preferably 250 ° C or less, most preferably 200 ° C or less, most preferably 90-150 ° C.
  • Completely dehydrated alum (also referred to as fired alum) or partially dewatered alums can be better dispersed, at least in higher concentrations, than alums having a water content of less than 12 molecules per molecule.
  • Alum particles suitable for the compositions according to the invention are those which have a number-average particle size of 0.1-150 ⁇ m, preferably 1-80 ⁇ m, particularly preferably 5-60 ⁇ m and extraordinarily preferably 10-30 ⁇ m.
  • compositions according to the invention as a double salt of alum Type b) the KAI (SO 4 ) 2 .12H 2 O.
  • the stated amounts and water of crystallization contents refer to the raw material used in the preparation of the compositions according to the invention Since the compositions according to the invention contain water in a preferred embodiment, the double salts are in the aqueous Phase dissolved before and thus have in the product no water of crystallization, but are dissociated.
  • compositions of the invention contain at least one double salt of the alum type having the general formula M I M I "(S0 4) 2 ⁇ x H 2 0, where M 1 is a monovalent cation selected from potassium, sodium, rubidium, Cesium and ammonium ions, M 1 "represents a trivalent cation selected from aluminum, gallium, indium, scandium, titanium and vanadium ions, and x represents a rational number in the range of 0 to 12, including 0, preferably 12, represents, in a total amount of 0.01 to 10 wt .-%, preferably 0.05 to 5 wt .-%, particularly preferably 0.1 to 2 wt .-%, most preferably 0.3 - 1 wt .-%, each based on the total weight of the composition according to the invention.
  • M 1 is a monovalent cation selected from potassium, sodium, rubidium, Cesium and ammonium ions
  • M 1 represents a trivalent cation selected from aluminum, gallium, in
  • compositions of the invention contain at least one double salt of the alum type b), is selected (from KAI S0 4) 2, KAI (S0 4) 2 ⁇ 1 H 2 0, KAI (S0 4) 2 ⁇ 2H 2 0, KAI (S0 4 ) 2 ⁇ 3 H 2 0, KAI (S0 4 ) 2 ⁇ 4 H 2 0, KAI (S0 4 ) 2 ⁇ 5 H 2 0, KAI (S0 4 ) 2 ⁇ 6 H 2 0, KAI (S0 4 ) 2 ⁇ 7 H 2 0, KAI (S0 4 ) 2 ⁇ 8 H 2 0, KAI (S0 4 ) 2 ⁇ 9 H 2 0, KAI (S0 4 ) 2 ⁇ 10 H 2 0, KAI (S0 4 ) 2 ⁇ 1 H z O and KAI (S0 4 ) 2 ⁇ 12 H 2 O, and mixtures thereof, in a total amount of 0.01 to 10 wt .-%, preferably 0.05 to 5 wt .-%, especially preferably w
  • compositions of the invention contain KAI (S0 4) 2 ⁇ 12 H 2 0 in a total amount from 0.01 to 10 wt .-%, preferably 0.05 to 5 wt .-%, particularly preferably 0.1 to 2 wt. -%, most preferably 0.3 to 1 wt .-%, each based on the total weight of the composition according to the invention.
  • compositions of the invention based on their weight - 1 to 50 wt .-% ethanol and / or isopropanol.
  • ethanol is preferred over isopropanol.
  • the amount of ethanol be greater than the amount of isopropanol.
  • Particularly preferred compositions according to the invention Based on their weight - 5 to 45 wt .-%, preferably 10 to 40 wt .-%, more preferably 15 to 37.5 wt .-% and in particular 20 to 35 wt .-% ethanol.
  • compositions of the invention can be regulated in their viscosity, in particular polysaccharides have proven to be thickeners.
  • Polysaccharides which are suitable according to the invention are understood as meaning both unmodified polysaccharides, such as, for example, xanthan or starch, and chemically modified polysaccharide derivatives, such as, for example, aluminum starch octenylsuccinate or hydroxypropylmethylcellulose, and physically modified polysaccharides, for example a starch pregelatinized by thermal treatment.
  • Preferred polysaccharides according to the invention are selected from starches, in particular from corn, potatoes and wheat, their constituents such as amylose and amylopectin, starch hydrolysates and starch degradation products, such as maltodextrin, the physically or chemically modified starch derivatives, in particular the anionic starch derivatives Aluminium Staroctenylsuccinat, Natrium Positionoctenylsuccinat, Calcium Whyoctenylsuccinat, Ditialphosphaten , Hydroxyethyl starch phosphates, hydroxypropyl starch phosphates, sodium carboxymethyl starches and sodium starch glycolate, cellulose, the chemically modified cellulose derivatives methylcellulose, hydroxypropylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose, hydroxypropylethylcellulose, hydroxyethylmethylcellulose and carboxymethylcellulose.
  • compositions according to the invention are free of polysaccharide gums.
  • compositions according to the invention comprise at least one polysaccharide in a total amount of 0.01-1.0% by weight, preferably 0.05-0.5 and more preferably 0.2-0.4% by weight, based in each case on Total weight of the composition.
  • compositions according to the invention are characterized in that they contain at least one polysaccharide in a total amount of 0.01-1.0% by weight, preferably 0.05-0.5 and particularly preferably 0.09-0.2% by weight. %, each based on the total weight of the composition, and the polysaccharide is selected from anionic and nonionic polysaccharides and mixtures thereof.
  • compositions of the present invention include an anionic polysaccharide selected from aluminum starch octenyl succinate, sodium starch octenyl succinate, calcium starch octenyl succinate, distarch phosphates, hydroxyethyl starch phosphates, hydroxypropyl starch phosphates, sodium carboxymethyl starches, sodium starch glycolate, and mixtures thereof.
  • anionic polysaccharide selected from aluminum starch octenyl succinate, sodium starch octenyl succinate, calcium starch octenyl succinate, distarch phosphates, hydroxyethyl starch phosphates, hydroxypropyl starch phosphates, sodium carboxymethyl starches, sodium starch glycolate, and mixtures thereof.
  • compositions according to the invention contain, based on their weight, 0.01 to 10% by weight, preferably 0.05 to 7.5% by weight, more preferably 0.1 to 5% by weight and in particular 0, 25-2.5% by weight of at least one nonionic polysaccharide selected from starches, starch hydrolysates, cellulose, methyl cellulose, hydroxypropyl cellulose, Hydroxyethylcellulose, hydroxypropylmethylcellulose, hydroxypropylethylcellulose, hydroxyethylmethylcellulose and mixtures thereof.
  • nonionic polysaccharide selected from starches, starch hydrolysates, cellulose, methyl cellulose, hydroxypropyl cellulose, Hydroxyethylcellulose, hydroxypropylmethylcellulose, hydroxypropylethylcellulose, hydroxyethylmethylcellulose and mixtures thereof.
  • compositions of the invention may contain a minor amount of an oil or fat phase of 0.5-6.5% by weight, based on the weight of the total composition.
  • the low level of dispersed oil or fat phase results in an improved, non-greasy skin feel.
  • Preferred oil components are selected from adducts of at least 6 propylene oxide units per molecule of monovalent or polyvalent C 3 .
  • 30 -alkanols in particular butanol, butanediol, myristyl alcohol and stearyl alcohol, from propylene glycol monoesters of branched saturated C 6 -C 30 -alkanecarboxylic acids, branched saturated C 0 -C 30 -alkanols, particularly preferably selected from PPG-3-myristyl ether, PPG-13 Butyl ether, PPG-14 butyl ether, PPG-9 butyl ether, PPG-10-butanediol, PPG-15 stearyl ether, propylene glycol monoisostearate, propylene glycol monoisopalmitate, propylene glycol monoisobehenate, propylene glycol monoisoarachinate, propylene glycol monoiso-myristate, propylene glycol mono
  • compositions according to the invention may contain emulsifiers, with nonionic emulsifiers having proven particularly useful. Among these, those with HLB values in the range of 12 to 18 are again particularly preferred.
  • compositions preferred according to the invention are characterized in that at least one nonionic emulsifier having an HLB value in the range of 12-18 is present, which is selected from linear saturated and unsaturated C 2 -C 30 -alkanols having from 10 to 100 ethylene oxide units etherified per molecule, with steareth, ceteth, ceteareth, myristeth, laureth, trideceth, araffleth and beheneth each having 10 to 100 ethylene oxide units per molecule being preferred.
  • compositions which are preferred according to the invention comprise, based in each case on their weight, 0.25-5% by weight, preferably 0.5-4, more preferably 0.75-3% and in particular 1-2.5% by weight of ceteareth-12 and 0.25 - 5 wt .-%, preferably 0.5 - 4, more preferably 0.75 - 3 and in particular 1 - 2.5 wt .-% Ceteareth-30th
  • the compositions according to the invention may contain 0.0005-1% by weight, based on the total composition, of at least one silicon oxide-containing compound selected from hydrophilic silicic acids and / or hydrophobic modified silicic acids and / or phyllosilicates.
  • Preferred hydrophobicized phyllosilicates are selected from hydrophobized montmorillonites, hydrophobized hectorites and hydrophobized bentonites, more preferably distearonium hectorites, stearalkonium hectorites, quaternium-18 hectorites and quaternium-18 bentonites.
  • hydrophobicized phyllosilicates are preferred in the form of a gel in an oil component, preferably in cyclomethicones and / or a non-silicone oil component, such as. For example, propylene carbonate.
  • the gelation takes place by the addition of small amounts of activators, in particular ethanol or propylene carbonate, but also water.
  • activators in particular ethanol or propylene carbonate, but also water.
  • Such gels are for example available under the trade name Bentone ® or Thixogel.
  • Preferred compositions according to the invention comprise at least one activator in a total amount of 0.1-3% by weight, preferably 0.3-2.0% by weight, in each case based on the total weight of the composition according to the invention.
  • compositions according to the invention comprise at least one activator selected from ethanol, propylene carbonate and water and mixtures thereof, in a total amount of 0.1-3% by weight, preferably 0.3-2.0% by weight, based in each case on the total weight of the composition of the invention.
  • Preferred compositions according to the invention are characterized in that they comprise at least one hydrophobicized layered silicate in a total amount of 0.5-7% by weight, preferably 1-3.5% by weight, particularly preferably 2-3% by weight, in each case on the total weight of the composition according to the invention.
  • Hydrophobically modified silicas which are preferred according to the invention are selected from hydrophobically modified pyrogenic silicic acids, eg. As the commercial products of Aerosil ® series from Evonik Degussa, particularly preferably silica silylate, and silica dimethyl silylate.
  • compositions which are preferred according to the invention are characterized in that they contain at least one hydrophobically modified silicic acid, preferably at least one hydrophobically modified pyrogenic silicic acid, in a total amount of 0.5-3.5% by weight, preferably 0.8-3% by weight, more preferably 1 to 2.5 wt .-%, most preferably 1, 5 to 2 wt .-%, each based on the total weight of the composition according to the invention, included.
  • compositions are characterized in that they contain at least one hydrophobized fumed silica and at least one hydrophilic silica.
  • Hydrophilic silicas which are preferred according to the invention are selected from silicon dioxide which is not modified organically or inorganically and has no organic or inorganic coating.
  • the above-mentioned feature "no organic or inorganic coating” refers to the state of the hydrophilic silica before it is mixed with the other constituents of the compositions according to the invention After mixing it is quite possible for individual constituents of the formulation to be present on the surface of the hydrophilic silica sorbed, the feature "no organic or inorganic coating" remains unaffected. Also possibly sorbed gases do not apply according to the invention as a coating. Hydrophilic silicas which are preferred according to the invention are obtainable by precipitation.
  • hydrophilic silicas preferred according to the invention comprise based on the weight of the hydrophilic silica, at least 80 wt .-% spherical silica particles.
  • Further hydrophilic silicas which are preferred according to the invention comprise, based on the weight of the hydrophilic silica, at least 80% by weight of silicon dioxide particles having a number-average particle diameter in the range from 2 to 15 ⁇ m, particularly preferably in the range from 5 to 10 ⁇ m.
  • Further preferred hydrophilic silicas according to the invention comprise, based on the weight of the hydrophilic silica, at least 80% by weight of silica particles having an oil absorption capacity of 0.7-1.5 cm 3 of liquid paraffin per gram of dry silicon dioxide, measured to DIN 53601.
  • hydrophilic silicas which are preferred according to the invention are obtainable by precipitation and comprise more than 80% by weight of spherical silica particles. Further inventively preferred hydrophilic silicas are obtainable by precipitation and comprise more than 80 wt .-% silica particles having a number average particle diameter in the range of 2-15 ⁇ , more preferably in the range of 5-10 ⁇ . Further hydrophilic silicas which are preferred according to the invention are obtainable by precipitation and comprise more than 80% by weight of spherical silica particles having a number-average particle diameter in the range from 2 to 15 ⁇ m, particularly preferably in the range from 5 to 10 ⁇ m. Further inventively preferred hydrophilic silicas are pyrogenic, so not available by precipitation.
  • hydrophilic silicic acids are available as commercial product SB-705 from Miyoshi Kasei, a spherical silica gel or spherical silica particles with the INCI name Silica having a number-average particle diameter of 5 to 6 ⁇ m and a specific surface area of about 600 m 2 / g.
  • Further preferred hydrophilic silicic acids are available as a commercial product Aerosil from Evonik Degussa, for example Aerosil 130, Aerosil 200, Aerosil 255, Aerosil 300 or Aerosil 380.
  • hydrophilic silicas are also available as commercial products: CAB-O-SIL Fumed Silica (Cabot), CAB-O-SIL EH-5 (Cabot), CAB-O-SIL HS-5 (Cabot), CAB-O-SIL LM-130 (Cabot), CAB-O-SIL MS-55 (Cabot), CAB- O-SIL M-5 (Cabot), Cosmedia Silc (Cognis), Neosil PC 50S (Ineos Silica), Sorbosil BFG 54 (Ineos Silica), Sorbosil AC33 (Ineos Silica), Sorbosil AC 35 (Ineos Silica), Sorbosil AC 37 (Ineos Silicas), Sorbosil AC 39 (Ineos Silica), Wacker HDK N 20 (Wacker chemistry), Wacker HDK S 13 (Wacker chemistry), Wacker HDK T 30 (Wacker chemistry), Wacker HDK V 15 (Wacker
  • compositions preferred according to the invention comprise at least one hydrophilic silica in a total amount of 0.0005-1% by weight, preferably 0.001-0.5% by weight, particularly preferably 0.01-0.4% by weight, most preferably 0.05-0.3% by weight and more preferably 0.1-0.2% by weight, based in each case on the total composition.
  • compositions according to the invention have been developed in particular for roll-on products, that is to say for application with a ball applicator or roll-on applicator.
  • the composition must not be too viscous or too viscous.
  • Compositions which are preferred according to the invention are therefore characterized by a viscosity in the range from 800 to 5000 mPas, preferably from 1000 to 4000 mPas and particularly preferably from 1500 to 2200 mPas.
  • viscosity data refer to measurements with a Brookfield viscometer, which is carried out 1 day after preparation of the composition with spindle RV 4, at a shear rate (spindle speed) of 20 s " without helipath at an ambient temperature and a sample temperature of 20 ° C.
  • compositions according to the invention contain at least one deodorising aromatic alcohol of the structure (AA-1),
  • R - R 6 independently a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and which may be substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, or an alkenyl group having 2 to 10 Carbon atoms which may be linear or branched and which may be substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms
  • R 7 - R independently a hydrogen atom, a halogen atom, in particular a chlorine atom, or an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and which may be substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, in particular having a methoxy group
  • m 0 or 1
  • n, o, p are independently integers from 0 to 10, wherein at least one of the values n, o, p is 0.
  • Deodorising aromatic alcohols of structure (AA-1) which are preferred according to the invention are selected from phenoxyethanol, phenoxyisopropanol (3-phenoxy-propan-2-ol), anisalcohol, 2-methyl-5-phenyl-pentane-1-ol, 1,1 Dimethyl 3-phenylpropane-1-ol, benzyl alcohol, 2-phenylethane-1-ol, 3-phenylpropan-1-ol, 4-phenylbutan-1-ol, 5-phenylpentan-1-ol, 2-benzylheptane -1-ol, 2,2-dimethyl-3-phenylpropan-1-ol, 2,2-dimethyl-3- (3'-methylphenyl) propan-1-ol, 2-ethyl-3-phenylpropan-1 - ol, 2-ethyl-3- (3'-methylphenyl) -propan-1-ol, 3- (3'-chlorophenyl) -2-ethyl-prop
  • Examples of the C to C 5 -alkyl radicals mentioned as substituents in the compounds used according to the invention are the groups methyl, ethyl, propyl, isopropyl, n-butyl, tert-butyl, n-pentyl, amyl, isoamyl.
  • Ethyl, methyl, propyl, isopropyl, n-butyl, tert-butyl, n-pentyl, amyl, isoamyl are preferred alkyl radicals, particularly preferred are methyl and n-pentyl.
  • C 4 -C 4 -alkoxy radicals which are preferred according to the invention are, for example, a methoxy or an ethoxy group.
  • a C to C 5 hydroxyalkyl group there may be mentioned a hydroxymethyl, a 2-hydroxyethyl, a 3-hydroxypropyl or a 4-hydroxybutyl group.
  • a 2-hydroxyethyl group is particularly preferred.
  • a particularly preferred C 2 to C 4 polyhydroxyalkyl group is the 1,2-dihydroxyethyl group.
  • halogen atoms are F, Cl or Br atoms, Cl atoms are very particularly preferred.
  • Particularly preferred deodorant aromatic alcohols of structure (AA-1) according to the invention are selected from anisalcohol, 2-methyl-5-phenyl-pentane-1-ol, 1, 1-dimethyl-3-phenyl-propan-1-ol, 3 Phenylpropan-1-ol, 4-phenylbutan-1-ol, 5-phenylpentan-1-ol, 2-benzylheptan-1-ol, 2,2-dimethyl-3-phenylpropan-1-ol and 2-n-pentyl 3-phenylpropane-1-ol. Extraordinary preference is given to 2-benzylheptene-1-ol.
  • compositions according to the invention contain in addition to the at least one deodorant double salt of the alum type b) and in addition to the claimed component c) at least one further deodorant active ingredient.
  • deodorant active ingredients are selected from mineral deodorant active substances, odor absorbers, inorganic moisture absorbers, deodorizing ion exchangers, germ-inhibiting substances, prebiotic substances and also enzyme inhibitors and, particularly preferred, combinations of said deodorant active substances.
  • the mineral deodorant or moisture absorbents preferably include odor-absorbing and / or moisture-absorbing silicates such.
  • Unmodified silicates serve as odor absorbers or moisture absorbers, which at the same time advantageously support the rheological properties of the composition according to the invention.
  • the silicates which are particularly advantageous according to the invention include, in particular, unmodified phyllosilicates and, among these, in particular montmorillonite, kaolinite, IIIit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talcum.
  • Such mineral deodorant or moisture absorbents are preferably in a total amount of 0.1 to 5 wt .-%, preferably 0.5 to 3 wt .-%, particularly preferably 0.7 to 2 wt .-%, each based on the entire composition, included.
  • Further advantageous odor absorbers are, for example, zinc ricinoleate, cyclodextrins, certain metal oxides, such as. As alumina, and chlorophyll.
  • germ-inhibiting or antimicrobial active substances are understood to mean those wrinkles which reduce the number of skin germs participating in the formation of the odor or inhibit their growth.
  • These organisms include, among others, various species from the group of staphylococci, the group of corynebacteria, anaerococci and micrococci.
  • Preferred germinal or antimicrobial active substances according to the invention are in particular organohalogen compounds and halides, quaternary ammonium compounds, a series of plant extracts and zinc compounds.
  • triclosan chlorhexidine and chlorhexidine gluconate
  • 3,4,4'-trichlorocarbanilide bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol, dequalinium chloride, domiphen bromide, ammonium phenolsulfonate, benzalkonium halides, benzalkonium cetyl phosphate, benzene alkoniumsaccharinate, benzethonium chloride, cetylpyridinium chloride, laurylpyridinium chloride, laurylisoquinolinium bromide, methylbenzedonium chloride.
  • phenol disodium dihydroxyethylsulfosuccinyl undecylenate, sodium bicarbonate, zinc lactate, sodium phenolsulfonate and zinc phenolsulfonate, ketoglutaric acid, terpene alcohols such as.
  • chlorophyllin copper complexes ⁇ -monoalkyl glycerol ether with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 alkyl, particularly preferably a- (2-ethylhexyl) glycerol, commercially available as Sensiva ® SC 50 (ex Schülke & Mayr), carboxylic acid esters of mono-, di- and triglycerol (eg glycerol monolaurate, diglycerol monocaprinate), lantibiotics and plant extracts (eg green tea and components of lime blossom oil).
  • Sensiva ® SC 50 ex Schülke & Mayr
  • carboxylic acid esters of mono-, di- and triglycerol eg glycerol monolaurate, diglycerol monocaprinate
  • lantibiotics and plant extracts eg green tea and components of lime blossom oil.
  • deodorant active substances are selected from so-called prebiotically active components, which according to the invention are to be understood as meaning those components which inhibit only or at least predominantly the odor-causing germs of the skin microflora, but not the desired ones, that is, the non-odor-forming germs forming a include healthy skin microflora.
  • active ingredients which are disclosed in the published patent applications DE 10333245 and DE 10 2004 01 1 968 as prebiotically effective, also included; these include conifer extracts, in particular from the group of Pinaceae, and plant extracts from the group of Sapindaceae, Araliaceae, Lamiaceae and Saxifragaceae, in particular extracts from Picea spp., Paullinia sp., Panax sp., Lamium album or Ribes nigrum and mixtures of these substances.
  • the enzyme inhibitors include substances which inhibit the enzymes responsible for the sweat decomposition, in particular the arylsulfatase, ⁇ -glucuronidase, aminoacylase, cystathionine beta-lyase esterases, lipases and / or lipoxigenase, e.g. B. trialkylcitric acid, in particular triethyl citrate, or zinc glycinate.
  • Further preferred deodorant impurities are selected from silver salts, in particular silver citrate, dihydrogen silver citrate, silver lactate and silver sulfate, soluble complex salts of silver, colloidal silver and silver zeolites.
  • compositions according to the invention comprise at least one additional deodorant active ingredient chosen from silver salts, soluble complex salts of silver, colloidal silver and silver zeolites, arylsulfatase inhibitors, ⁇ -glucuronidase inhibitors, aminoacylase inhibitors, cystathionine beta-lyase inhibitors, esterase Inhibitors, lipase inhibitors and lipoxygenase inhibitors, ⁇ -monoalkyl glycerol ethers having a branched or linear saturated or unsaturated, optionally hydroxylated C 6 -C 22 -alkyl radical, in particular a- (2-ethylhexyl) glycerol ether, prebiotic components, trialkyl citric acid esters , in particular triethyl citrate, active substances which reduce or inhibit the growth of the number of odoriferous skin microorganisms from the group of staphylococci, corynebacteria, anaerococci, micrococci
  • compositions contain at least one additional deodorant active ingredient in a total amount of 0.1-10% by weight, preferably 0.2-7% by weight, more preferably 0.3-5% by weight and most preferably 0.4 - 1, 0 wt .-%, further preferably 0.5 - 0.9 and 0.6 - 0.8 wt .-%, based on the total weight of the active substance in the total composition.
  • Further compositions preferred according to the invention comprise at least one further mineral deodorant active or sweat-absorbent or moisture-absorbent, with particularly preferred compositions containing the additional mineral / deodorant active ingredient or sweat absorbents or moisture absorbents in a total amount of 0.1-5% by weight. -%, preferably 0.5 to 3 wt .-%, particularly preferably 0.7 to 2 wt .-%, each based on the total composition.
  • compositions contain 0.01 to 5 wt .-%, preferably 0.05 to 2 wt .-%, particularly preferably 0.1 to 1 wt .-%, each based on the total composition, one of a natural mineral water , a thermal water or a natural healing mineral mixture obtained.
  • Natural mineral water is based on the definition of the German Mineral and Table Water Ordinance (MinTafWV, ⁇ 2) .
  • the mineral mixture is considered to be the solid residue of the named waters.
  • Occupationally preferred mineral mixtures originate from the thermal water of La Toja (Spain), Bad Blumau, Bad Radkersburg, Aachen, Wiesbaden (all Germany), Carlsbad (Czech Republic), La Bourboule, Enghien-les-bains, Allevard-les-bains, Digne, Nyrac-les-bains, Lons le Saunier, Eaux Bonnes, Rochefort, les Fumades, Saint Christau, Uriage-les-bains, la Roche-Posay (all France) or the natural mineral or medicinal waters of Evian, Volvic, Vichy, Avene, Vittel (all France), Gerolstein or laboringen (Germany).
  • Antioxidant substances can counteract the oxidative decomposition of the welding components and in this way inhibit odor development.
  • Preferred antioxidants are imidazole and imidazole derivatives (eg urocaninic acid), peptides, such as e.g. B.
  • D, L-carnosine, D-carnosine, L-carnosine and their derivatives eg, anserine
  • carotenoids eg, carotenes (eg, ⁇ -carotene, ⁇ -carotene, lycopene) and their derivatives
  • Lipoic acid and its derivatives eg dihydrolipoic acid
  • aurothioglucose propylthiouracil and other thio compounds
  • Ethyl, propyl, amyl, butyl, lauryl, palmitoyl, oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters and their salts, dilauryl thiodipropionat
  • Suitable derivatives (salts, esters, sugars, nucleotides, nucleosides, peptides and lipids) and mixtures of these active substances or anhydrous plant extracts containing these antioxidants can be used according to the invention.
  • Preferred lipophilic, oil-soluble antioxidants from this group are tocopherol and its derivatives, in particular tocopheryl acetate, and carotenoids, as well as butylhydroxytoluene and butylhydroxyanisole.
  • the total amount of antioxidants in preferred compositions according to the invention is 0.001-10% by weight, preferably 0.05-5% by weight and especially 0.1-2% by weight, based on the total composition.
  • compositions according to the invention therefore contain at least one complexing agent.
  • the compositions according to the invention contain at least one organic UV filter substance.
  • the organic UV filters preferred according to the invention are selected from the derivatives of dibenzoylmethane, cinnamic esters, diphenylacrylic acid esters, benzophenone, camphor, p-aminobenzoic acid esters, o-aminobenzoic acid esters, salicylic acid esters, benzimidazoles, symmetrically or unsymmetrically substituted 1,3,5-triazines , monomeric and oligomeric 4,4-Diarylbutadiencarbonklareestern and -carbonklare- amides, Ketotricyclo (5.2.1 .0) decane, Benzalmalonklareestern, benzoxazole and any mixtures of the above components.
  • the organic UV filters can be oil-soluble or water-soluble.
  • the benzoxazole derivatives are advantageously present in dissolved form in the cosmetic preparations according to the invention.
  • Preferred compositions according to the invention comprise at least one organic UV filter substance in a total amount of 0.1-30% by weight, preferably 0.5-20% by weight, more preferably 1.0-10% by weight and most preferably 2 or 3 - 7 wt .-%, each based on the total composition.
  • compositions contain at least one perfume.
  • perfumes, perfume oils or perfume oil ingredients can be used.
  • perfume oils or fragrances can according to the invention individual fragrance compounds, eg. As the synthetic products of the ester type, ethers, aldehydes, ketones, alcohols and hydrocarbons.
  • Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert.-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinyl acetate (DMBCA), phenylethyl acetate, benzyl acetate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, benzylsalicylate, cyclohexylsalicylate, floramate, melusate and jasmecyclate.
  • DMBCA dimethylbenzylcarbinyl acetate
  • benzyl acetate ethylmethylphenylglycinate
  • allylcyclohexylpropionate styrallylpropionate
  • benzylsalicylate cyclohexylsal
  • the ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes, for example, the linear alkanals with 8-18 C-atoms, citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, lilial and bourgeonal, to the ketones eg the Jonone, alpha-lsomethylionon and methyl cedryl ketone, to the alcohols anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes such as limonene and pinene.
  • fragrance oils may also contain natural fragrance mixtures as are available from vegetable sources, eg pine, citrus, jasmine, patchouly, rose or ylang-ylang oil.
  • perfume oils may also contain natural fragrance mixtures as are available from vegetable sources, eg pine, citrus, jasmine, patchouly, rose or ylang-ylang oil.
  • oils may also contain natural fragrance mixtures as are available from vegetable sources, eg pine, citrus, jasmine, patchouly, rose or ylang-ylang oil.
  • suitable are Muskateller sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, lime blossom oil, juniper berry oil, vetiver oil, olibanum oil, galbanum oil and laudabean oil and orange blossom oil, neroli oil, orange peel oil and sandalwood oil.
  • Particularly preferred cosmetic compositions according to the invention contain at least one perfume in a total amount of 0.00001-4 wt .-%, preferably 0.5-2 wt .-%, particularly preferably 1-1, 5 wt .-%, each based on the total composition.
  • compositions preferred according to the invention are packaged in a container with ball applicator or roll-on applicator.
  • Another object of the present invention is the cosmetic, non-therapeutic use of a composition according to the invention, for antiperspirant treatment of the skin, in particular the armpit skin and / or the skin of the feet.
  • Another object of the present invention is a cosmetic, non-therapeutic method for deodorizing skin treatment, which is characterized in that a composition according to the invention is applied in an effective amount to the skin.
  • Another object of the present invention is a cosmetic, non-therapeutic method for antiperspirant treatment of the skin, in particular the underarm skin and / or the foot skin, which is characterized in that a composition according to the invention is applied in an effective amount to the skin.
  • Another object of the present invention is the cosmetic, non-therapeutic use of a composition according to the invention for the deodorizing treatment of the skin.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des compositions d'antitranspirant contenant de l'alcool, qui sont particulièrement adaptées à une application par applicateur à bille, présentent une longue durée de conservation, confèrent une sensation non grasse à la peau et sont améliorées par leur effet antitranspirant et déodorant. Ces compositions contiennent 1 à 50 % en poids d'éthanol et/ou d'isopropanol et au moins un sel double de type alun de formule générale MIMIII(SO4)2 ⋅ x H2O, MI = un cation monovalent sélectionné dans le groupe comprenant des ions de potassium, de sodium, de rubidium, de césium et d'ammonium; MIII = un cation trivalent sélectionné dans le groupe comprenant des ions d'aluminium, de gallium, d'indium, de scandium, de titane et de vanadium; x = un nombre rationnel de 0 à 12, y compris 0.
PCT/EP2011/062611 2010-07-23 2011-07-22 Antitranspirants contenant de l'alcool et du sel double Ceased WO2012010685A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102010038356.2 2010-07-23
DE102010038356A DE102010038356A1 (de) 2010-07-23 2010-07-23 Doppelsalz-haltige alkoholische Antitranspirantien

Publications (2)

Publication Number Publication Date
WO2012010685A2 true WO2012010685A2 (fr) 2012-01-26
WO2012010685A3 WO2012010685A3 (fr) 2013-12-12

Family

ID=44629006

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/062611 Ceased WO2012010685A2 (fr) 2010-07-23 2011-07-22 Antitranspirants contenant de l'alcool et du sel double

Country Status (2)

Country Link
DE (1) DE102010038356A1 (fr)
WO (1) WO2012010685A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10086035B2 (en) 2016-02-04 2018-10-02 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
US10493011B2 (en) 2017-08-03 2019-12-03 ALASTIN Skincare, Inc. Peptide compositions and methods for ameliorating skin laxity and body contour
US10722435B2 (en) 2016-06-17 2020-07-28 Conopco, Inc. Deodorant products
US11103455B2 (en) 2018-08-02 2021-08-31 ALASTIN Skincare, Inc. Liposomal compositions and methods of use

Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
GB1347950A (en) 1971-03-08 1974-02-27 Bristol Myers Co Antiperspirant aerosol system
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
US4017599A (en) 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6436381B1 (en) 2000-10-25 2002-08-20 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 al content
US6663854B1 (en) 2002-06-19 2003-12-16 Yan-Fei Shen Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio
US20040009133A1 (en) 2002-07-12 2004-01-15 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
US6902723B2 (en) 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
DE10333245A1 (de) 2003-07-21 2005-07-28 Henkel Kgaa Präbiotisch wirksame Pflanzenextrakte
US6923952B2 (en) 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium
DE102004011968A1 (de) 2004-03-10 2005-09-29 Henkel Kgaa Präbiotisch wirksame Pflanzenextrakte
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2259587A1 (en) 1974-02-04 1975-08-29 Procter & Gamble Zirconium or hafnium oxyhalide anti-perspirant cpds - used in compsns with aluminium cpds and amino acids
GB2299506B (en) 1995-04-03 1999-04-14 Unilever Plc Antiperspirant actives and compositions
DE20210904U1 (de) * 2002-07-19 2003-08-21 Holzlehner, Frank, 30625 Hannover Desodorierende Zubereitung zur Anwendung auf der menschlichen haut

Patent Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
GB1347950A (en) 1971-03-08 1974-02-27 Bristol Myers Co Antiperspirant aerosol system
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
US4017599A (en) 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
US6074632A (en) 1997-06-25 2000-06-13 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6245325B1 (en) 1998-08-19 2001-06-12 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6436381B1 (en) 2000-10-25 2002-08-20 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 al content
US6649152B2 (en) 2000-10-25 2003-11-18 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 Al content
US6663854B1 (en) 2002-06-19 2003-12-16 Yan-Fei Shen Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio
US20040009133A1 (en) 2002-07-12 2004-01-15 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine
DE10333245A1 (de) 2003-07-21 2005-07-28 Henkel Kgaa Präbiotisch wirksame Pflanzenextrakte
US6902723B2 (en) 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
US6923952B2 (en) 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium
DE102004011968A1 (de) 2004-03-10 2005-09-29 Henkel Kgaa Präbiotisch wirksame Pflanzenextrakte

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10086035B2 (en) 2016-02-04 2018-10-02 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
US10286030B2 (en) 2016-02-04 2019-05-14 Alastin Skincare, Inc Compositions and methods for invasive and non-invasive procedural skincare
US10688147B2 (en) 2016-02-04 2020-06-23 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
US11426443B2 (en) 2016-02-04 2022-08-30 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
US11426442B2 (en) 2016-02-04 2022-08-30 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
US12357671B2 (en) 2016-02-04 2025-07-15 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
US10722435B2 (en) 2016-06-17 2020-07-28 Conopco, Inc. Deodorant products
US10493011B2 (en) 2017-08-03 2019-12-03 ALASTIN Skincare, Inc. Peptide compositions and methods for ameliorating skin laxity and body contour
US11052032B2 (en) 2017-08-03 2021-07-06 ALASTIN Skincare, Inc. Peptide compositions and methods for ameliorating skin laxity and body contour
US11752084B2 (en) 2017-08-03 2023-09-12 ALASTIN Skincare, Inc. Methods for fat reduction or elimination of lipid droplets
US11103455B2 (en) 2018-08-02 2021-08-31 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
US12053547B2 (en) 2018-08-02 2024-08-06 ALASTIN Skincare, Inc. Liposomal compositions and methods of use

Also Published As

Publication number Publication date
DE102010038356A1 (de) 2012-01-26
WO2012010685A3 (fr) 2013-12-12

Similar Documents

Publication Publication Date Title
WO2012010684A2 (fr) Applicateurs à bille antitranspiration contenant des sels doubles
DE60213209T2 (de) Wasserfreie schweisshemmende und deodorierende zusammensetzungen enthaltend feste pantothenatsalze
DE102010063250A1 (de) Wasserhaltige Antitranspirant-Zusammensetzungen mit verbesserter Rückstandsmaskierung
DE102008053034A1 (de) Verwendung von Hydroxyzimtsäuren und ihren Derivaten und/oder von Pflanzenextrakten zur Behandlung von Körpergeruch
EP2451426A2 (fr) Compositions cosmétiques contenant des suspensions de sels d'argent
DE102015225958A1 (de) Kosmetische Mittel, enthaltend eine Kombination von mindestens zwei verschiedenen Wirkstoffen
WO2012010685A2 (fr) Antitranspirants contenant de l'alcool et du sel double
EP3057665A1 (fr) Agent cosmétique anti-transpiration contenant des lactates
US20240407982A1 (en) Personal Care Compositions
EP3057564A1 (fr) Produit cosmétique anti-transpirant contenant des acides amidosulfoniques
US20230310289A1 (en) Personal Care Compositions and Methods
EP3057568B1 (fr) Utilisation de l'acide méthanesulfonique et de ses sels pour l'activation et/ou stabilisation des sels d'aluminium anti-transpirants
EP3057566A1 (fr) Agent cosmétique anti-transpirant contenant des acides polyphosphoriques
EP3057565A2 (fr) Agent cosmétique anti-transpirant comprenant des acides polycarboxyliques
EP3057666A1 (fr) Agent cosmétique anti-transpiration contenant des acides sulfoniques aromatiques
DE102010038357A1 (de) Doppelsalz-haltige Antitranspirant-Stifte
EP2994089B1 (fr) Composition d'aérosol présentant des propriétés de pulvérisation améliorées
DE102009027052A1 (de) Schweißhemmende Zusammensetzungen mit Silbercitrat
EP3057567A2 (fr) Produits cosmétiques anti-transpirants aux alpha-hydroxyacides
WO2014202235A1 (fr) Compositions anhydres contre les odeurs corporelles
DE102016205698A1 (de) Wasserfreie Antitranspirantien enthaltend emulgatorbeladene Kieselsäurepartikel
EP3027167A1 (fr) Mélanges anhydres huile/épaississant comme base pour des préparations cosmétiques solides souples et/ou en bâton
WO2015085996A1 (fr) Produits cosmétiques antitranspirants contenant du lysozyme et/ou de l'albumine de sérum bovin et/ou de la protéine de yaourt
DE102013220782A1 (de) Schweißhemmende kosmetische Mittel mit Phenylcarbonsäuren

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 11736089

Country of ref document: EP

Kind code of ref document: A2